Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$223M |
| 2 |
CVS Health
CVS
|
+$18.9M |
| 3 |
American International
AIG
|
+$16.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.4M |
| 5 |
TJX Companies
TJX
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$12.6M |
| 2 |
Crown Castle
CCI
|
+$7.91M |
| 3 |
Eli Lilly
LLY
|
+$7.58M |
| 4 |
RTX Corp
RTX
|
+$7.28M |
| 5 |
Deere & Co
DE
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.16% |
| 2 | Consumer Discretionary | 11.77% |
| 3 | Financials | 11.5% |
| 4 | Healthcare | 9.84% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
DELISTED
Trinseo
TSE
| $438K | 0.03% |
+10,200
| New | +$448K |
2016 Q2
0 quarters
|
|
602
Spire
SR
$5.25B
| $437K | 0.03% |
+6,174
| New | +$406K |
2016 Q2
0 quarters
|
|
|
GWB
603
DELISTED
Great Western Bancorp, Inc.
GWB
| $437K | 0.03% |
+13,870
| New | +$432K |
2016 Q2
0 quarters
|
|
604
Rio Tinto
RIO
$135B
| $436K | 0.03% |
+13,931
| New | +$416K |
2016 Q2
0 quarters
|
|
605
Verisk Analytics
VRSK
$26.2B
| $436K | 0.03% |
5,378
-1,184
| -18% | -$92.9K |
2016 Q1
1 quarter
|
|
606
TETRA Technologies
TTI
$819M
| $435K | 0.03% |
68,305
+54,718
| +403% | +$337K |
2015 Q4
2 quarters
|
|
607
Criteo S.A.
CRTO
$733M
| $434K | 0.03% |
9,445
| – | – |
2015 Q1
5 quarters
|
|
608
InterDigital
IDCC
$8.14B
| $434K | 0.03% |
7,791
-5,284
| -40% | -$299K |
2015 Q3
3 quarters
|
|
609
Amdocs
DOX
$6.63B
| $433K | 0.03% |
7,500
-3,600
| -32% | -$206K |
2015 Q4
2 quarters
|
|
610
O-I Glass
OI
$801M
| $433K | 0.03% |
+24,054
| New | +$441K |
2016 Q2
0 quarters
|
|
611
Tenet Healthcare
THC
$21.4B
| $430K | 0.03% |
15,551
-19,325
| -55% | -$571K |
2015 Q2
4 quarters
|
|
612
DELISTED
Regal Entertainment Group
RGC
| $428K | 0.03% |
+19,400
| New | +$403K |
2016 Q2
0 quarters
|
|
613
Itron
ITRI
$4.38B
| $427K | 0.03% |
+9,907
| New | +$418K |
2016 Q2
0 quarters
|
|
614
Becton Dickinson
BDX
$54.1B
| $425K | 0.03% |
+2,571
| New | +$411K |
2016 Q2
0 quarters
|
|
615
Dine Brands
DIN
$462M
| $423K | 0.03% |
4,995
-754
| -13% | -$64.7K |
2016 Q1
1 quarter
|
|
616
Myriad Genetics
MYGN
$560M
| $419K | 0.03% |
13,680
-7,420
| -35% | -$258K |
2015 Q4
2 quarters
|
|
|
BID
617
DELISTED
Sotheby's
BID
| $419K | 0.03% |
15,299
-8,403
| -35% | -$238K |
2015 Q4
2 quarters
|
|
618
LSB Industries
LXU
$796M
| $416K | 0.03% |
+44,751
| New | +$446K |
2016 Q2
0 quarters
|
|
619
DELISTED
Assertio
ASRT
| $415K | 0.03% |
353
-1,671
| -83% | -$1.83M |
2015 Q4
2 quarters
|
|
620
Moog Inc Class A
MOG.A
$11.3B
| $410K | 0.03% |
+7,600
| New | +$384K |
2016 Q2
0 quarters
|
|
621
United Therapeutics
UTHR
$25.6B
| $410K | 0.03% |
3,874
-16,302
| -81% | -$1.82M |
2015 Q4
2 quarters
|
|
622
Huntington Bancshares
HBAN
$32.3B
| $404K | 0.03% |
+45,226
| New | +$445K |
2016 Q2
0 quarters
|
|
623
LendingTree
TREE
$380M
| $403K | 0.03% |
+4,560
| New | +$386K |
2016 Q2
0 quarters
|
|
624
Opko Health
OPK
$1.28B
| $402K | 0.03% |
+43,000
| New | +$437K |
2016 Q2
0 quarters
|
|
|
BEL
625
DELISTED
Belmond Ltd.
BEL
| $401K | 0.03% |
+40,526
| New | +$380K |
2016 Q2
0 quarters
|
|
Similar funds
Squarepoint's Q2 2016 Portfolio in Review
As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.
- Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
- Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
- Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
- Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
- Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
- Squarepoint opened 435 new positions and closed 482 in Q2 2016.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.
Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.